Strategic Collaborations Clear Creek Bio has established collaborations with Pfizer and NIH on antiviral targets, signaling strong partner credibility and potential for additional co-development or CRO partnerships in protease and related antiviral programs.

Growth and Outsourcing With a recent round of funding and a lean team, the company is well positioned to pursue outsourced clinical development, regulatory support, and manufacturing partnerships to accelerate clinical plans.

Antiviral Focus The focus on SARS-CoV-2 and other viruses creates demand for antiviral discovery services such as high-throughput screening, assay development, and medicinal chemistry collaborations.

Cambridge Advantage Located in Cambridge, MA, Clear Creek Bio can leverage local biotech ecosystems for partnerships with contract research, data analytics, and cloud-enabled development capabilities.

Credibility Engine Prior and ongoing collaborations with Pfizer and NIH provide credibility to attract additional pharma partners, investors, and grant opportunities for expansion.